These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 17097359)
1. Biomarker discovery from body fluids using mass spectrometry. Villar-Garea A; Griese M; Imhof A J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Apr; 849(1-2):105-14. PubMed ID: 17097359 [TBL] [Abstract][Full Text] [Related]
2. Unravelling in vitro variables of major importance for the outcome of mass spectrometry-based serum proteomics. West-Nørager M; Kelstrup CD; Schou C; Høgdall EV; Høgdall CK; Heegaard NH J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):30-7. PubMed ID: 17112795 [TBL] [Abstract][Full Text] [Related]
3. Reproducibility of serum protein profiling by systematic assessment using solid-phase extraction and matrix-assisted laser desorption/ionization mass spectrometry. Callesen AK; Christensen Rd; Madsen JS; Vach W; Zapico E; Cold S; Jørgensen PE; Mogensen O; Kruse TA; Jensen ON Rapid Commun Mass Spectrom; 2008; 22(3):291-300. PubMed ID: 18181248 [TBL] [Abstract][Full Text] [Related]
4. Surface-enhanced laser desorption/ionization mass spectrometry for protein and Peptide profiling of body fluids. Gagnon A; Shi Q; Ye B Methods Mol Biol; 2008; 441():41-56. PubMed ID: 18370310 [TBL] [Abstract][Full Text] [Related]
5. FTMS and TOF/TOF mass spectrometry in concert: identifying peptides with high reliability using matrix prespotted MALDI target plates. Dekker LJ; Burgers PC; Guzel C; Luider TM J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):62-4. PubMed ID: 16963321 [TBL] [Abstract][Full Text] [Related]
6. In-source decay causes artifacts in SELDI-TOF MS spectra. Ekblad L; Baldetorp B; Fernö M; Olsson H; Bratt C J Proteome Res; 2007 Apr; 6(4):1609-14. PubMed ID: 17373843 [TBL] [Abstract][Full Text] [Related]
7. Biomarker discovery in serum/plasma using surface enhanced laser desorption ionization time of flight (SELDI-TOF) mass spectrometry. Ndao M Methods Mol Biol; 2012; 818():67-79. PubMed ID: 22083816 [TBL] [Abstract][Full Text] [Related]
8. Biomarker discovery for kidney diseases by mass spectrometry. Niwa T J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(2):148-53. PubMed ID: 18024247 [TBL] [Abstract][Full Text] [Related]
9. Cardiovascular biomarker discovery by SELDI-TOF mass spectrometry. Meilhac O; Delbosc S; Michel JB Methods Mol Biol; 2007; 357():331-41. PubMed ID: 17172699 [TBL] [Abstract][Full Text] [Related]
10. A new rapid and comprehensive peptidome analysis by one-step direct transfer technology for 1-D electrophoresis/MALDI mass spectrometry. Tanaka K; Tsugawa N; Kim YO; Sanuki N; Takeda U; Lee LJ Biochem Biophys Res Commun; 2009 Jan; 379(1):110-4. PubMed ID: 19073144 [TBL] [Abstract][Full Text] [Related]
11. Derivatized cellulose combined with MALDI-TOF MS: a new tool for serum protein profiling. Feuerstein I; Rainer M; Bernardo K; Stecher G; Huck CW; Kofler K; Pelzer A; Horninger W; Klocker H; Bartsch G; Bonn GK J Proteome Res; 2005; 4(6):2320-6. PubMed ID: 16335981 [TBL] [Abstract][Full Text] [Related]
12. Modified silver nanoparticle as a hydrophobic affinity probe for analysis of peptides and proteins in biological samples by using liquid-liquid microextraction coupled to AP-MALDI-ion trap and MALDI-TOF mass spectrometry. Shrivas K; Wu HF Anal Chem; 2008 Apr; 80(7):2583-9. PubMed ID: 18324794 [TBL] [Abstract][Full Text] [Related]
13. Opportunities and limitations of SELDI-TOF-MS in biomedical research: practical advices. Poon TC Expert Rev Proteomics; 2007 Feb; 4(1):51-65. PubMed ID: 17288515 [TBL] [Abstract][Full Text] [Related]
14. Peptidomic analysis of human blood specimens: comparison between plasma specimens and serum by differential peptide display. Tammen H; Schulte I; Hess R; Menzel C; Kellmann M; Mohring T; Schulz-Knappe P Proteomics; 2005 Aug; 5(13):3414-22. PubMed ID: 16038021 [TBL] [Abstract][Full Text] [Related]
15. ProteoMiner™ and SELDI-TOF-MS: a robust and highly reproducible combination for biomarker discovery from whole blood serum. Fröbel J; Hartwig S; Passlack W; Eckel J; Haas R; Czibere A; Lehr S Arch Physiol Biochem; 2010; 116(4-5):174-80. PubMed ID: 20662595 [TBL] [Abstract][Full Text] [Related]
16. Serum protein profiling in patients with inflammatory bowel diseases using selective solid-phase bulk extraction, matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and chemometric data analysis. Nanni P; Parisi D; Roda G; Casale M; Belluzzi A; Roda E; Mayer L; Roda A Rapid Commun Mass Spectrom; 2007; 21(24):4142-8. PubMed ID: 18022963 [TBL] [Abstract][Full Text] [Related]
17. Ultra-fast mass fingerprinting by high-affinity capture of peptides and proteins on derivatized poly(glycidyl methacrylate/divinylbenzene) for the analysis of serum and cell lysates. Rainer M; Muhammad NU; Huck CW; Feuerstein I; Bakry R; Huber LA; Gjerde DT; Zou X; Qian H; Du X; Wei-Gang F; Ke Y; Bonn GK Rapid Commun Mass Spectrom; 2006; 20(19):2954-60. PubMed ID: 16953521 [TBL] [Abstract][Full Text] [Related]
18. Proteomic data analysis workflow for discovery of candidate biomarker peaks predictive of clinical outcome for patients with acute myeloid leukemia. Forshed J; Pernemalm M; Tan CS; Lindberg M; Kanter L; Pawitan Y; Lewensohn R; Stenke L; Lehtiö J J Proteome Res; 2008 Jun; 7(6):2332-41. PubMed ID: 18452325 [TBL] [Abstract][Full Text] [Related]
19. A novel approach using MALDI-TOF/TOF mass spectrometry and prestructured sample supports (AnchorChip Technology) for proteomic profiling and protein identification. Leung SM; Pitts RL Methods Mol Biol; 2008; 441():57-70. PubMed ID: 18370311 [TBL] [Abstract][Full Text] [Related]
20. Quantitative quality-assessment techniques to compare fractionation and depletion methods in SELDI-TOF mass spectrometry experiments. Harezlak J; Wang M; Christiani D; Lin X Bioinformatics; 2007 Sep; 23(18):2441-8. PubMed ID: 17626063 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]